title: Cutaneous tuberculosis: diagnosis, histopathology and treatment - part II.
abstract: The evolution in the knowledge of tuberculosis' physiopathology allowed not only a better understanding of the immunological factors involved in the disease process, but also the development of new laboratory tests, as well as the establishment of a histological classification that reflects the host's ability to contain the infectious agent. At the same time, the increasing bacilli resistance led to alterations in the basic tuberculosis treatment scheme in 2009. This article critically examines laboratory and histological investigations, treatment regimens for tuberculosis and possible adverse reactions to the most frequently used drugs.
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Josemir Belo dos
authors: JB
authors: Santos
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Ana Roberta
authors: AR
authors: Figueiredo
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Cláudia Elise
authors: CE
authors: Ferraz
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Márcia Helena de
authors: MH
authors: Oliveira
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Perla Gomes da
authors: PG
authors: Silva
authors: Universidade Federal de Pernambuco, Recife, PE, Brazil.
authors: Vanessa Lucília Sileira de
authors: VL
authors: Medeiros
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006099:Granuloma; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009169:Mycobacterium tuberculosis; D009336:Necrosis; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D014382:Tuberculosis, Cutaneous / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin